Literature DB >> 15058595

High-performance liquid-chromatographic determination of rifampicin in plasma and tissues.

Ignacio Calleja1, María J Blanco-Príeto, Noelia Ruz, María Jesús Renedo, María Carmen Dios-Viéitez.   

Abstract

A HPLC-UV method has been developed for assaying rifampicin in plasma and liver. The assay involved a liquid-liquid extraction procedure with dichloromethane-pentane (1:1). An Ultrabase-C18 column and a simple mobile phase consisting of a water (pH 2.27)-acetonitrile (40:60, v/v) mixture were used. The flow-rate was 1 ml/min and the effluent was monitored at 333 nm. Results from the HPLC analyses showed that the assay method is linear in the ranges 0.1-1 and 1-50 microg/ml for plasma, and 0.6-40 microg/g for liver. Intra- and inter-day R.S.D. were below 15% for all the sample types. Recoveries averaged 83 and 95% for plasma and liver, respectively. The method is being successfully applied to determine rifampicin in plasma and liver samples taken during pharmacokinetic studies in rats.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15058595     DOI: 10.1016/j.chroma.2003.12.041

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  8 in total

1.  Intracellular time course, pharmacokinetics, and biodistribution of isoniazid and rifabutin following pulmonary delivery of inhalable microparticles to mice.

Authors:  Rahul Kumar Verma; Jatinder Kaur; Kaushlendra Kumar; Awadh Bihari Yadav; Amit Misra
Journal:  Antimicrob Agents Chemother       Date:  2008-06-30       Impact factor: 5.191

2.  Addition of gentamicin or rifampin does not enhance the effectiveness of daptomycin in treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.

Authors:  J M Miró; C García-de-la-Mària; Y Armero; D Soy; A Moreno; A del Río; M Almela; M Sarasa; C A Mestres; J M Gatell; M T Jiménez de Anta; F Marco
Journal:  Antimicrob Agents Chemother       Date:  2009-07-20       Impact factor: 5.191

3.  Quantification of rifampicin in human plasma and cerebrospinal fluid by a highly sensitive and rapid liquid chromatographic-tandem mass spectrometric method.

Authors:  Abhishek Srivastava; David Waterhouse; Alison Ardrey; Stephen A Ward
Journal:  J Pharm Biomed Anal       Date:  2012-06-01       Impact factor: 3.935

4.  Detection of residual rifampicin in urine via fluorescence quenching of gold nanoclusters on paper.

Authors:  Krishnendu Chatterjee; Chiung Wen Kuo; Ann Chen; Peilin Chen
Journal:  J Nanobiotechnology       Date:  2015-06-26       Impact factor: 10.435

5.  Prolonged-acting, multi-targeting gallium nanoparticles potently inhibit growth of both HIV and mycobacteria in co-infected human macrophages.

Authors:  Prabagaran Narayanasamy; Barbara L Switzer; Bradley E Britigan
Journal:  Sci Rep       Date:  2015-03-06       Impact factor: 4.379

6.  Long-acting antituberculous therapeutic nanoparticles target macrophage endosomes.

Authors:  Benson J Edagwa; Dongwei Guo; Pavan Puligujja; Han Chen; JoEllyn McMillan; Xinming Liu; Howard E Gendelman; Prabagaran Narayanasamy
Journal:  FASEB J       Date:  2014-08-13       Impact factor: 5.191

7.  Theoretically Guided Analytical Method Development and Validation for the Estimation of Rifampicin in a Mixture of Isoniazid and Pyrazinamide by UV Spectrophotometer.

Authors:  Mohammad F Khan; Shamima A Rita; Md Shahidulla Kayser; Md Shariful Islam; Sharmeen Asad; Ridwan Bin Rashid; Md Abdul Bari; Muhammed M Rahman; D A Anwar Al Aman; Nurul I Setu; Rebecca Banoo; Mohammad A Rashid
Journal:  Front Chem       Date:  2017-04-28       Impact factor: 5.221

8.  Assessment of lactoferrin-conjugated solid lipid nanoparticles for efficient targeting to the lung.

Authors:  Satish Shilpi; Vishnoo Dayal Vimal; Vandana Soni
Journal:  Prog Biomater       Date:  2015-03-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.